Protecting the Critical Path in Medical Device and Pharmaceutical Testing Programmes
When packaging and distribution testing supports critical development and submission milestones, how it is planned and managed can matter as much as the testing itself.
For medical device and pharmaceutical teams, packaging and distribution testing can sit directly on the critical path.
Leaving requirements until late in a programme can create significant risk - particularly if laboratory capacity is limited, protocols are still being developed or testing identifies an issue when there is little time left to respond.
But timing is only part of the challenge. Internal teams may also lack the time, specialist testing knowledge or laboratory capability to plan and coordinate a complex programme alongside their other development priorities.
When testing becomes a programme challenge
Depending on the project, testing may extend beyond packaging performance to include assessment of the packaged product through distribution testing, testing to support pharmaceutical stability studies or evaluation of the primary packaging system.Whatever the scope, successful delivery can depend on getting multiple elements aligned:
- Testing requirements and acceptance criteria
- Protocol development and approval
- Sample and fixture readiness
- Laboratory capacity and test sequencing
- Results and reporting against key decision dates
Taking a managed approach
A managed testing programme brings the technical and practical elements together from the outset. Smithers can work with teams to understand the programme requirements and critical dates, define and sequence testing, develop protocols, coordinate test readiness and reserve laboratory capacity around key milestones.During delivery, activities and dependencies can be managed through a coordinated schedule, with clear progress updates and early escalation of issues where required. This gives internal teams greater visibility of the programme without requiring them to manage every aspect of the testing themselves.
Explore the managed testing approach. See how technical planning, programme coordination and testing can work together to help protect critical milestones in the downloadable article.
Protecting critical milestones
Early planning cannot guarantee that testing will not identify an unexpected problem - nor should it. The value is in creating sufficient time and visibility to respond to findings before they become significantly more disruptive.For teams working towards design freeze, validation, regulatory submission or commercial release, a managed approach can help reduce late-stage testing risk, reduce pressure on internal resources and keep technical evidence aligned with the wider development schedule.
Smithers combines specialist medical and pharmaceutical packaging expertise with extensive distribution testing capabilities, including combined-hazard shipment simulation and assessment of packaging and packaged-product performance under expected distribution conditions. Our ISO 17025-accredited and ISTA-certified laboratories support programmes from early technical planning and protocol development through testing, coordination and reporting.
Planning packaging and distribution testing around a critical development, validation or submission milestone?
